Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
GLP-1 agonists and SGLT-2 inhibitors are recommended for high-risk individuals with type 2 diabetes, regardless of A1C levels, to: Reduce risk of heart attack, stroke, and other major adverse cardiovascular events (MACE)
GLP-1 neurons that target one region, such as the hypothalamus, thalamus, or bed nucleus of the stria terminalis, have axon collaterals that branch widely and reach every central target that is known to receive GLP-1 input, including the spinal cord
Syringes: Sterile syringes for drawing and injecting the water and peptide solution
Environment Canada
US$ 24.07
US$ 25.51
US$ 20.35
